|
Market Closed -
Euronext Paris
11:55:00 2026-08-12 EDT
|
5-day change | 1st Jan Change | ||
| 155.50 EUR | +0.06% |
|
-0.89% | +30.67% |
| 08-04 | Marengo Therapeutics, Inc. and Ipsen S.A. Nominate First Drug Candidate Under Strategic Tristar Collaboration | CI |
| 08-03 | Jefferies Downgrades Ipsen to Underperform, Boosts PT | MT |
| Market Cap | 12.75B 14.7B 11.95B 10.89B 20.48B 1,401B 20.81B 141B 54.87B 703B 55.16B 53.96B 2,342B | P/E 2026 * |
12.9x | P/E 2027 * | 13.7x |
|---|---|---|---|---|---|
| Enterprise Value | 11.52B 13.28B 10.8B 9.84B 18.5B 1,265B 18.79B 127B 49.57B 635B 49.83B 48.74B 2,116B | EV / Sales 2026 * |
2.53x | EV / Sales 2027 * | 2.3x |
| Free-Float |
40.65% | Yield 2026 * |
0.99% | Yield 2027 * | 0.99% |
Last Transcript: Ipsen
| 1 day | +0.06% | ||
| 1 week | -0.89% | ||
| Current month | -7.00% | ||
| 1 month | -4.43% | ||
| 3 months | -5.47% | ||
| 6 months | +12.03% | ||
| Current year | +30.67% |
| 1 week | 153.7 |  | 163.9 |
| 1 month | 153.1 | | 174 |
| Current year | 116 | | 174 |
| 1 year | 107 | | 174 |
| 3 years | 87.95 | | 174 |
| 5 years | 77 | | 174 |
| 10 years | 34.2 | | 174 |
| Manager | Title | Age | Since |
|---|---|---|---|
David Loew
CEO | Chief Executive Officer | 59 | 2020-06-30 |
| Chief Executive Officer | 57 | 2019-12-31 | |
Pierrick Lefranc
CTO | Chief Tech/Sci/R&D Officer | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
Antoine Flochel
BRD | Director/Board Member | 61 | 2005-08-29 |
| Chairman | 68 | 2010-11-21 | |
Carol Xueref
BRD | Director/Board Member | 69 | 2012-05-31 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 7/31/26 | Fiscal year | Chief Executive Officer | -5,000 | 0.0060% | ||
| 2/25/26 | Sell | Chairman | 3,800 | 0.0045% | ||
| 5/29/25 | Fiscal year | Chief Executive Officer | 28,008 | 0.0334% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.06% | -0.89% | +47.11% | +28.41% | 14.7B | |
| +0.43% | +9.38% | +92.10% | +130.99% | 1,083B | |
| +0.41% | +2.33% | +50.07% | +50.05% | 626B | |
| -0.53% | +2.03% | +25.23% | +63.46% | 442B | |
| -0.92% | +2.18% | +48.40% | +37.85% | 363B | |
| -1.32% | -0.32% | +29.35% | +36.81% | 295B | |
| -1.20% | -0.32% | +6.03% | +6.09% | 248B | |
| +0.45% | +6.71% | +45.98% | +58.54% | 224B | |
| -2.51% | -2.63% | -7.16% | -51.74% | 210B | |
| +0.07% | +0.46% | +12.78% | +69.84% | 168B | |
| Average | -0.58% | +2.49% | +34.99% | +43.03% | 367.38B | |
| Weighted average by Cap. | -0.39% | +4.27% | +49.43% | +65.81% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 4.55B 5.25B 4.27B 3.89B 7.31B 500B 7.43B 50.29B 19.6B 251B 19.7B 19.27B 836B | 4.57B 5.27B 4.29B 3.9B 7.34B 502B 7.46B 50.49B 19.67B 252B 19.78B 19.35B 840B |
| Net income | 1B 1.15B 939M 855M 1.61B 110B 1.63B 11.06B 4.31B 55.21B 4.33B 4.24B 184B | 960M 1.11B 900M 820M 1.54B 106B 1.57B 10.61B 4.13B 52.94B 4.16B 4.06B 176B |
| Net Debt | -1.23B -1.42B -1.16B -1.05B -1.98B -135B -2.01B -13.61B -5.3B -67.94B -5.33B -5.22B -226B | -2.24B -2.58B -2.1B -1.91B -3.6B -246B -3.66B -24.75B -9.64B -124B -9.7B -9.48B -412B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-08-12 | €155.50 | +0.06% | 101,777 |
| 26-08-11 | €155.40 | -1.83% | 101,074 |
| 26-08-10 | €158.30 | -2.04% | 115,723 |
| 26-08-07 | €161.60 | -0.19% | 107,122 |
| 26-08-06 | €161.90 | +1.38% | 108,916 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- IPN Stock
Select your edition
All financial news and data tailored to specific country editions
